Brigatinib + Mao Inhibitors Interaction
Moderateinteraction on record
Description
Coadministration increases brigatinib plasma concentrations, which may increase the incidence of adverse reactions. Dose reduction recommended if coadministration unavoidable.
Mechanism
CYP3A inhibition increases brigatinib exposure
Source: NLP:brigatinib